With this issue of Evidence-Based GI: An ACG Publication, Joseph C. Anderson, MD, FACG and Paul Y. Kwo, MD, FACG, take over as co-Editor-in-Chiefs as the founding editor, Philip Schoenfeld, MD, MSEd, MScEpi, FACG completes his term. Dr Schoenfeld launched EBGI in October 2021, with a straightforward goal: to provide structured abstracts on the best clinical GI, hepatology, and endoscopy research published in US- and non-US-based general medicine journals using evidence-based methods. Each abstract is paired with editorial commentary on how physicians can apply this research to their practice. Since the inaugural issue, EBGI has covered 147 articles published in 17 medical journals, including 25 articles from the ACG’s own flagship journal, The American Journal of Gastroenterology. This coverage has allowed our readers access to GI-related information covered in top tiered journals such as New England Journal of Medicine, Lancet, and Annals of Internal Medicine. Each month an electronic table of contents is sent to all ACG members worldwide, and the podcasts are accessed through popular platforms such as Spotify and iTunes—but are also available directly through the gi.org website. The ACG will soon be offering podcasts through YouTube in 2025. In Dr Schoenfeld’s last year as Editor-in-Chief, he worked with the EBGI Social Media Ambassadors to develop slides for journal clubs based on the EBGI summaries. These slides can be downloaded from the website and used freely for educational purposes. Drs Anderson and Kwo will continue these popular features and thank Dr Schoenfeld for his work to establish the publication.
About the Editors
Dr Paul Kwo is currently the Director of Hepatology and Professor of Medicine at Stanford University School of Medicine. Dr. Kwo was Professor of Medicine at Indiana University and the Medical Director of Liver Transplantation where he distinguished himself in the field of viral hepatitis and served as the principal investigator for multiple seminal trials that established the efficacy of direct acting antiviral agents for the treatment of both non-transplant and post-transplant hepatitis C hepatitis C infection. His clinical and research interests are in novel therapeutic approaches to treat viral hepatitis including hepatitis B and C elimination and other chronic liver diseases. He has served on the editorial boards of multiple journals including Hepatology, Hepatology Communications, and the Journal of Clinical Gastroenterology. He also is an Associate Editor for Clinical and Molecular Hepatology as well serving as co-Editor-in-Chief for Current Hepatology reports. He has served on numerous ACG committees including the Education Committee, International Relations Committee, and was the Chair of the ACG Credentials Committee. He is a director of the ACG Hepatology Circle, as well as the ACG Hepatology School and served on the ACG Board of Trustees from 2016 to 2022.
Dr Joseph C Anderson is a full-time gastroenterologist at the White River Junction VAMC, Professor of Medicine at the Geisel School of Medicine at Dartmouth University, and an Associate Professor of Medicine at the University of Connecticut School of Medicine. His research focuses on colorectal cancer screening, and he is a member of the US Multi-Society Task Force on Colorectal Cancer. Dr Anderson serves on the editorial boards of The American Journal of Gastroenterology, GIE, Endoscopy, and CGH, and is an Associate Editor at Journal of Clinical Gastroenterology. Dr Anderson has served on numerous ACG committees including the Practice Parameters Committee, Research Committee, Educational Affairs, Practice Management, and was Chair of the Professionalism Committee. He also has served as an ACG Governor for New Hampshire.